Nascent Pharma Holdings, Inc. (NASC)
OTCMKTS · Delayed Price · Currency is USD
0.0147
0.00 (0.00%)
At close: Jul 23, 2026

Nascent Pharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
0.010.030.070.450.460.05
Cash & Short-Term Investments
0.010.030.070.450.460.05
Cash Growth
-74.84%-53.54%-83.70%-1.92%883.67%-94.24%
Accounts Receivable
1.423.726.593.6521.25
Receivables
1.423.726.593.652.011.28
Inventory
0.161.622.022.550.340.78
Prepaid Expenses
0.0100.0200.011.28
Other Current Assets
--0----
Total Current Assets
1.595.388.76.652.823.39
Property, Plant & Equipment
-4.46.579.271.051.17
Goodwill
-----0.06
Other Intangible Assets
-0.10.110.37-1.34
Other Long-Term Assets
0.260.250.180.180.041.26
Total Assets
1.8610.1315.5616.473.917.21

Liabilities

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Accounts Payable
2.631.953.141.160.150.23
Accrued Expenses
--0.182.410.20.21
Short-Term Debt
0.460.360.30.22-0.04
Current Portion of Long-Term Debt
8.568.577.954.871.83-
Current Portion of Leases
-0.250.650.810.040.04
Other Current Liabilities
-00.2---
Total Current Liabilities
11.6411.1312.429.462.230.51
Long-Term Debt
----0.19-
Long-Term Leases
--0.441.390.020.06
Total Liabilities
11.6411.1312.8610.862.440.56

Shareholders' Equity

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Common Stock
84.8283.2679.6149.6830.8724.32
Additional Paid-In Capital
11.5610.48.015.642.721.46
Retained Earnings
-113.93-102.43-92.69-77.77-65.6-24.67
Treasury Stock
-0.57-0.57-0.57-0.57-0.57-
Comprehensive Income & Other
0.120.120.12---
Total Common Equity
-18.01-9.22-5.52-23.03-32.571.11
Shareholders' Equity
-9.79-12.75.621.486.65
Total Liabilities & Equity
1.8610.1315.5616.473.917.21

Additional Metrics

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Total Debt
9.019.189.347.282.080.13
Net Cash (Debt)
-9.01-9.15-9.26-6.84-1.62-0.09
Net Cash Growth
------
Net Cash Per Share
-0.19-0.73-2.59-5.09-6.89-0.62
Filing Date Shares Outstanding
75.8149.315.363.293.160.19
Total Common Shares Outstanding
70.1232.754.422.830.370.18
Working Capital
-10.05-5.75-3.72-2.810.592.88
Book Value Per Share
-0.26-0.28-1.25-8.12-88.126.21
Tangible Book Value
-18.01-9.32-5.63-23.4-32.57-0.29
Tangible Book Value Per Share
-0.26-0.28-1.27-8.25-88.12-1.60
Machinery
-7.647.587.831.211.17
Leasehold Improvements
-0.030.030.030.030.02